Open Access Highly Accessed Email this article to a friend

Evaluation of the cost effectiveness of exenatide versus insulin glargine in patients with sub-optimally controlled Type 2 diabetes in the United Kingdom

Anette Woehl*, Mark Evans, Anthony P Tetlow and Philip McEwan

Cardiovascular Diabetology 2008, 7:24 doi:10.1186/1475-2840-7-24

Fields marked * are required


Multiple email addresses should be separated with commas or semicolons.
How can I ensure that I receive Cardiovascular Diabetology's emails?